Hookipa Pharma Inc share price logo

Hookipa Pharma Inc

NASDAQ: HOOK

Small Cap

$1.18

-0.01

(-0.84%)

as on

Hookipa Pharma Inc Stock Performance

as on May 7, 2026 at 4:56 am IST

  • $1.18
    $1.18

  • 52 Week's Low

    52 Week's High

    $0.84
    $1.77
    downward going graph

    28.79%

    Downside

    49.99%

    Upside

    downward going graph

Hookipa Pharma Inc share price movements today

Previous Close
$1.19
Open
$1.18
Volume
305.4K
Day's Low - High
$1.18 - $1.18
52 Week Low - High
$0.84 - $1.77

Hookipa Pharma Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Hookipa Pharma Inc Stock Fundamentals & Key Indicators

Check Hookipa Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.6M

EPS (TTM)

-2.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-72.4M

Revenue (TTM)

9.4M

Profit Margin

0.00%

Return On Equity TTM

-105.79%

Hookipa Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Hookipa Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Hookipa Pharma Inc image
Hookipa Pharma Inc
BUY$14.6MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.5B130.77%76.3212.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.5BNA70.895.37%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$108.5B98.9%25.3835.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$75.6B45.15%17.629.65%

Analyst Recommendation on Hookipa Pharma Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Hookipa Pharma Inc. Average target price of $2

Hookipa Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Hookipa Pharma Inc.

What analysts predicted

41%UPSIDE

Target Price

$2

Current Price

$1.18

Analyzed by

12 Analysts

Target

$2.00

Hookipa Pharma Inc target price $2, a slight upside of 41% compared to current price of $1.18. According to 12 analysts rating.

Hookipa Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
3
2
6
7
36
1
4
1
2
6
Gross Profit
2
1
6
6
16
1
4
1
2
6
Operating Income
-22
-21
-22
-30
11
-22
-18
-21
-17
-6
EBITDA
-18
-17
-18
-23
15
-18
-13
-24
-15
-1
Interest Expense
0
0
0
0
0
-
-
-
-
-
Depreciation
0
0
0
1
0
0
0
0
0
0
Income Before Tax
-19
-18
-19
-24
14
-19
-13
-25
-15
-1
Income Tax Expense
0
0
0
0
0
-
-13
0
0
-
Net Income
-19
-18
-19
-24
14
-19
-13
-24
-15
-1
Net Profit Margin
-619.65%
-672.49%
-277.65%
-335.06%
39.30%
-1480.23%
-294.30%
-1842.69%
-769.81%
-26.28%

Hookipa Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
7
11
19
18
14
20
43
9
Gross Profit
0
-14
11
19
18
14
16
41
9
Operating Income
-14
-21
-51
-53
-81
-73
-97
-51
-36
EBITDA
-13
-14
-49
-49
-77
-69
-77
-40
-35
Interest Expense
0
0
0
0
0
0
0
0
-
Depreciation
0
0
1
4
4
3
3
2
-
Income Before Tax
-12
-16
-43
-44
-75
-64
-81
-43
-13
Income Tax Expense
0
0
-8
-10
0
0
0
0
0
Net Income
-12
-16
-34
-33
-75
-65
-81
-43
-13
Net Profit Margin
0.00%
-212.83%
-285.94%
-172.59%
-410.16%
-457.19%
-405.29%
-98.99%
-142.63%

Hookipa Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-18
-19
-24
14
-19
-13
-24
-15
-1
Operating Cash Flow
-19
-24
-11
-24
-14
-17
-20
0
-7
Investing Cash Flow
0
-3
0
0
0
0
0
0
-
Financing Cash Flow
45
0
21
0
-1
-
-
-
0
Change in Cash
25
-27
9
-24
-15
-17
-20
0
-6

Hookipa Pharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-43
-44
-75
-64
-81
-43
-13
Operating Cash Flow
-14
-41
-39
-66
-19
-57
-76
-11
Investing Cash Flow
-2
-1
-2
-12
-5
-4
0
6
Financing Cash Flow
6
109
73
0
72
65
-1
0
Change in Cash
-12
64
29
-76
46
4
-77
-2

Global Institutional Holdings in Hookipa Pharma Inc

Funds
Holdings
Northern Trust Corp
0%
JBF Capital, Inc.
0%
Baker Bros Advisors LP
6.67%
Siren, L.L.C.
4.65%
Acadian Asset Management LLC
0%
See all

Insights on Hookipa Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -24.95M → -15.42M (in $), with an average increase of 61.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.35M → 2.00M (in $), with an average increase of 32.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 62.7% return, outperforming this stock by 145.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 47.3% return, outperforming this stock by 141.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, HOOK stock has moved down by -28.0%

About Hookipa Pharma Inc

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.
OrganisationHookipa Pharma Inc
Headquarters350 Fifth Avenue, New York, NY, United States, 10118
IndustryBiotechnology
CEODr. Malte Peters M.D.
E-voting on sharesClick here to vote

Key Management of Hookipa Pharma Inc

Name

Title

Dr. Malte Peters M.D.

CEO, President & Director

Ms. Mary Theresa Coelho M.B.A.

Executive VP, CFO & Director

Dr. Daniel D. Pinschewer M.D.

Co-Founder & Member of Scientific Advisory Board

Dr. Mark Winderlich Ph.D.

Chief Research & Development Officer

FAQs

What is Hookipa Pharma Inc share price today?

Hookipa Pharma Inc share price today is $1.18 as on at the close of the market. Hookipa Pharma Inc share today touched a day high of $1.18 and a low of $1.18.

What is the 52 week high and 52 week low for Hookipa Pharma Inc share?

Hookipa Pharma Inc share touched a 52 week high of $1.77 on and a 52 week low of $0.84 on . Hookipa Pharma Inc stock price today i.e. is closed at $1.18,which is 33.33% down from its 52 week high and 40.43% up from its 52 week low.

What is Hookipa Pharma Inc's market capitalisation today?

Hookipa Pharma Inc market capitalisation is $0.00T as on .

How to invest in Hookipa Pharma Inc Stock (HOOK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Hookipa Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hookipa Pharma Inc Shares that will get you 1.2712 shares as per Hookipa Pharma Inc share price of $1.18 per share as on May 6, 2026 at 11:26 pm IST.

What is the minimum amount required to buy Hookipa Pharma Inc Stock (HOOK) from India?

Indian investors can start investing in Hookipa Pharma Inc (HOOK) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Hookipa Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Hookipa Pharma Inc share’s latest price of $1.18 as on May 6, 2026 at 11:26 pm IST, you will get 8.4746 shares of Hookipa Pharma Inc. Learn more about fractional shares .